Assignee
EMPIRICO INC
US·10 granted patents·30 pending applications·16 citations·filing 2019–2025
Top patents by PatentIndex Score
40 records- 0196US11879125B2GalNAc compositions for improving siRNA bioavailabilityEMPIRICO INC·Filed 2023·Granted Jan 23, 2024·3 cites·20 claims
- 0296US11116778B2Prodrugs of ALOX-15 inhibitors and methods of using the sameEMPIRICO INC·Filed 2020·Granted Sep 14, 2021·9 cites·9 claims
- 0394US11377658B2Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseasesEMPIRICO INC·Filed 2021·Granted Jul 5, 2022·2 cites·20 claims
- 0490US10941404B2Treatment of angiopoietin like 7 (ANGPTL7) related diseasesEMPIRICO INC·Filed 2020·Granted Mar 9, 2021·2 cites·20 claims
- 0584US2025090559A1Prodrugs of alox-15 inhibitors and methods of using the sameEMPIRICO INC·Filed 2024·Application pending·0 cites
- 0682US12258564B2GalNAc compositions for improving siRNA bioavailabilityEMPIRICO INC·Filed 2023·Granted Mar 25, 2025·0 cites·20 claims
- 0779US2023248752A1Prodrugs of alox-15 inhibitors and methods of using the sameEMPIRICO INC·Filed 2023·Application pending·0 cites
- 0878US12258563B2Modified oligonucleotidesEMPIRICO INC·Filed 2023·Granted Mar 25, 2025·0 cites·19 claims
- 0978US2025228883A1Process to Inhibit or Eliminate Eosinophilic Diseases of the Airway and Related ConditionsEMPIRICO INC·Filed 2024·Application pending·0 cites
- 1076US12312586B2Treatment of MST1 related diseases and disordersEMPIRICO INC·Filed 2024·Granted May 27, 2025·0 cites·8 claims
- 1175US11666588B2Prodrugs of ALOX-15 inhibitors and methods of using the sameEMPIRICO INC·Filed 2021·Granted Jun 6, 2023·0 cites·20 claims
- 1275US2024392295A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2024·Application pending·0 cites
- 1375US2025197863A1Galnac compositions for improving sirna bioavailabilityEMPIRICO INC·Filed 2025·Application pending·0 cites
- 1474US2026091053A1Treatment of thymic stromal lymphopoietin (tslp) related diseases by inhibition of long-form tslp transcriptsEMPIRICO INC·Filed 2025·Application pending·0 cites
- 1574US2024287523A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2024·Application pending·0 cites
- 1673US2023074280A1Treatment of thymic stromal lymphopoietin (tslp) related diseases by inhibition of long-form tslp transcriptsEMPIRICO INC·Filed 2022·Application pending·0 cites
- 1769US11452738B2Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcriptsEMPIRICO INC·Filed 2020·Granted Sep 27, 2022·0 cites·15 claims
- 1869US2026055410A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2025·Application pending·0 cites
- 1969US2022340907A1Oligonucleotides for treatment of angiopoietin like 4 (angptl4) related diseasesEMPIRICO INC·Filed 2022·Application pending·0 cites
- 2068US2024175031A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 2164US2025197859A1Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseasesEMPIRICO INC·Filed 2023·Application pending·0 cites
- 2263US12378556B2Treatment of angiopoietin like 7 (ANGPTL7) related diseasesEMPIRICO INC·Filed 2021·Granted Aug 5, 2025·0 cites·19 claims
- 2362US2024279663A1Treatment of angptl4 related diseasesEMPIRICO INC·Filed 2022·Application pending·0 cites
- 2462US2025195555A1Treatment of hgfac related diseases and disordersEMPIRICO INC·Filed 2023·Application pending·0 cites
- 2562US2025250568A1Modified oligonucleotidesEMPIRICO INC·Filed 2025·Application pending·0 cites
- 2661US2024018523A1Galnac compositions for improving sirna bioavailabilityEMPIRICO INC·Filed 2021·Application pending·0 cites
- 2761US2025327127A1Small molecule treatment of mtres1 related diseases and disordersEMPIRICO INC·Filed 2023·Application pending·0 cites
- 2861US2025313841A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2025·Application pending·0 cites
- 2961US2025333732A1Treatment of sos2 related diseases and disordersEMPIRICO INC·Filed 2023·Application pending·0 cites
- 3059US2025368990A1Treatment of ms4a4e related diseases and disordersEMPIRICO INC·Filed 2023·Application pending·0 cites
- 3157US2021361693A1Process to inhibit or eliminate eosinophilic diseases of the airway and related conditionsEMPIRICO INC·Filed 2019·Application pending·0 cites
- 3257US2023357774A1Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseasesEMPIRICO INC·Filed 2021·Application pending·0 cites
- 3356US2025043281A1Treatment of fgg related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3456US2024287519A1Treatment of dkk2 related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3555US2024287518A1Treatment of mtres1 related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3655US2024392299A1Treatment of mst1r related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3753US2024254492A1Modulation of coasy expressionEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3851US2024287517A1Treatment of plin1 related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3950US2023407299A1Treatment of sos2 related diseases and disordersEMPIRICO INC·Filed 2021·Application pending·0 cites
- 4050US2022056444A1Process to inhibit or eliminate eosinophilic diseases of the airway and related conditionsEMPIRICO INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →